RAPP
Rapport Therapeutics, Inc.
32.20$
-2.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | 100.0% | – | – | – | – | 100.0% | – | 100.0% | |
| – | – | – | – | – | 36.1% | – | – | – | – | 1.1% | – | – | |
| – | – | – | – | – | -36.1% | – | – | – | – | 100.0% | – | – | |
| – | – | – | – | – | 2,388.8% | – | – | – | – | 163.6% | – | 683.3% | |
| – | – | – | – | – | 878.1% | – | – | – | – | 57.5% | – | 184.2% | |
| – | – | – | – | – | 3,266.8% | – | – | – | – | 221.1% | – | 867.6% | |
| – | – | – | – | – | -3,266.8% | – | – | – | – | -121.1% | – | -767.6% | |
| – | – | – | – | – | -2,775.0% | – | – | – | – | -99.3% | – | -685.8% | |
| – | – | – | – | – | -2,775.0% | – | – | – | – | -99.3% | – | -685.8% | |
| – | – | – | – | – | -3,230.7% | – | – | – | – | -119.9% | – | -740.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.